Qingyang Wang Selected Research

Infections

1/2018	LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection.
1/2016	Neddylation is required for herpes simplex virus type I (HSV-1)-induced early phase interferon-beta production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingyang Wang Research Topics

Disease

4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2013
3	Neoplasms (Cancer) 05/2016 - 02/2008
2	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 01/2021
2	Inflammation (Inflammations) 12/2021 - 01/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 09/2013
2	Reperfusion Injury 01/2021 - 09/2013
2	Acute Promyelocytic Leukemia 01/2019 - 01/2018
2	Infections 01/2018 - 01/2016
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2016 - 12/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2016 - 12/2009
1	Papillary Thyroid Cancer 06/2022
1	Nodular Goiter 06/2022
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Infarction (Infarctions) 01/2021
1	Dehydration (Water Stress) 11/2018
1	Necrosis 12/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2016
1	Seizures (Absence Seizure) 03/2016
1	Shock 05/2015
1	Septic Shock (Toxic Shock Syndrome) 11/2014
1	Peritonitis 11/2014
1	Endotoxemia 11/2014
1	Myocardial Infarction 09/2013
1	Ischemia 09/2013
1	Carcinogenesis 01/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2013
4	Protein Kinases (Protein Kinase)IBA 09/2015 - 12/2009
2	LigandsIBA 12/2021 - 01/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 01/2018
2	Receptors for Activated C KinaseIBA 12/2016 - 01/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2016 - 09/2013
2	pevonedistatIBA 04/2016 - 01/2016
1	SolutionsIBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	tetramethylpyrazineIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	platelet activating factor receptorIBA 01/2021
1	3,4-dihydroxyphenyllactic acidIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2019
1	CobaltIBA 11/2018
1	CarbonIBA 11/2018
1	EnzymesIBA 01/2018
1	UbiquitinIBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Smad4 ProteinIBA 05/2016
1	Cullin Proteins (Cullins)IBA 04/2016
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 04/2016
1	3-n-butylphthalide (butylphthalide)IBA 03/2016
1	gamma-Aminobutyric Acid (GABA)IBA 03/2016
1	4- methyl- N1- (3- phenylpropyl)benzene- 1,2- diamineIBA 01/2016
1	Interferon-betaIBA 01/2016
1	Interferon Type IIBA 01/2016
1	RNA Splicing FactorsIBA 09/2015
1	Phosphotransferases (Kinase)IBA 09/2015
1	Growth Factor ReceptorsIBA 09/2015
1	CytokinesIBA 05/2015
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2014
1	Cholera ToxinIBA 11/2014
1	Carrier Proteins (Binding Protein)IBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	MAP Kinase Kinase 7IBA 01/2013
1	Interleukin-12 (IL 12)IBA 09/2010
1	Protein Isoforms (Isoforms)IBA 12/2009
1	Monoclonal AntibodiesIBA 02/2008

Therapy/Procedure

2	Therapeutics 01/2021 - 02/2008
1	Radiotherapy 03/2022
1	Drug Therapy (Chemotherapy) 03/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Adjuvant Chemotherapy 01/2021